Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.
US patent office grants patent claiming dosing regimen for TECFIDERA™ (dimethyl fumarate)
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
An older dog with newer tricks: Predicting efficacy of IFN-β treatment for multiple sclerosis.
Immunopathogenesis of neuromyelitis optica.
Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and the Cooperative Meeting with Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
MHC transmission: insights into gender bias in MS susceptibility.
Long-Term Effects of Exposure to Disease-Modifying Drugs in the Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart Review.
Blood Brain Barrier Meeting
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.
Episode 27 with Dr. Brenda Banwell on the new journal Multiple Sclerosis and Related Disorders
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
Summit 2013 + Expo
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis.
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
Gender and the hygiene hypothesis.
Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
Neurodegeneration: From Multiple Sclerosis to Alzheimer’s Disease
Spotlight on teriflunomide.
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
Integrating Acupuncture Within a Wellness Intervention for Women With Multiple Sclerosis: A Feasibility Study.
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
Episode 38 with Dr. Joseph Berger on progressive multifocal leukoencephalopathy

Pages